Showing results (171-180 of 291) with videos related to
Sort By:
Pageof 30
Journal of Medical Virology|May 16, 2012
Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1Norio Akuta, Fumitaka Suzuki, Yuya Seko, et al.BMC Nephrology|November 11, 2016
Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control studyTatsuya Suwabe, Yoshifumi Ubara, Toshiharu Ueno, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2014
HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapyTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.Journal of Medical Virology|February 27, 2020
Detection of TERT promoter mutation in serum cell-free DNA using wild-type blocking PCR combined with Sanger sequencing in hepatocellular carcinomaNorio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.Intervirology|August 22, 2012
Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapyYuya Seko, Norio Akuta, Fumitaka Suzuki, et al.Hepatology Communications|September 17, 2021
Ultrasensitive Assay for Hepatitis B Core-Related Antigen Predicts Hepatocellular Carcinoma Incidences During EntecavirTetsuya Hosaka, Fumitaka Suzuki, Mariko Kobayashi, et al.Internal Medicine (Tokyo, Japan)|May 26, 2020
SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver HistopathologyNorio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|November 8, 2011
[Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure]Norihiro Imai, Kenji Ikeda, Yuya Seko, et al.Hepatology International|March 20, 2022
Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver diseaseNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2010
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapyTetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.Pageof 30